Article Sidebar

PDF
Date Published: 11/09/2021
Abstract Views: 1695
Views PDF: 682
DOI: https://doi.org/10.51298/vmj.v505i1.1019
Issue
Vol. 505 No. 1 (2021)
Section
Các bài báo
How to Cite
Vân Nga, V. ., Thị Thu Thương, H. ., Thị Quỳnh, Đỗ ., Thị Mỹ Dung, Đinh ., Thị Bình Minh, N. ., Thị Lan Anh, N. ., Ngọc Thành, L. ., & Thị Thơm, V. . (2021). PREDICT THE RISK-10 YEARS OF CARDIOVASCULAR DISEASE ACCORDING TO FRAMINGHAM RISK SCORE IN TYPE 2 DIABETES MELLITUS PATIENTS. Vietnam Medical Journal, 505(1). https://doi.org/10.51298/vmj.v505i1.1019

PREDICT THE RISK-10 YEARS OF CARDIOVASCULAR DISEASE ACCORDING TO FRAMINGHAM RISK SCORE IN TYPE 2 DIABETES MELLITUS PATIENTS

Vũ Vân Nga1, Hà Thị Thu Thương1, Đỗ Thị Quỳnh1, Đinh Thị Mỹ Dung2, Nguyễn Thị Bình Minh2, Nguyễn Thị Lan Anh2, Lê Ngọc Thành1,2, Vũ Thị Thơm1,
1 University of Medicine and Pharmacy, Vietnam National University, Hanoi
2 E Hospital

Main Article Content

Abstract

Type 2 diabetes is rapidly increasing rate diseases with many dangerous complications, including an increased risk of blood vessel damage. It was estimated that 75% type 2 diabetic patients died as a result of cardiovascular diseases. However, in Vietnam, there have not been many studies evaluating the risk of cardiovascular disease in the next 10 years according to the Framingham Risk Score (FRS) in patients with type 2 diabetes. To predict the risk of cardiovascular disease in type 2 diabetic patients in the next 10 years and the factors related to this condition, we conducted a descriptive, cross-sectional study on 139 patients (62 men and 77 women) with type 2 diabetes, with an average age of 66.31 ± 8.88, showing that almost patients in very high risk (41.7%), high risk (17.3%), moderate risk (20.9%) and low risk (20.1%). The risk of caridovascular disease is higher in male patients, over 60 years old, with high body mass index, with dyslipidemia. For patients with type 2 diabetes and hypertension, the risk of cardiovascular disease is increased 10.784 times.

Article Details

Keywords

Type 2 diabetes mellitus, coronary artery disease, Framingham risk score

References

1. International Diabetes Federation (2019), IDF Diabetes Atlas Nine edition 2019.
2. Hammoud T và cộng sự(2000). Management of coronary artery disease: therapeutic options in patients with diabetes, Journal of the American College of Cardiology, 36(2):355-65.
3. American Diabetes Association (2020), 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020, Journal Diabetes Care, 43(Suppl 1), tr. S14
4. D’Agostino RB, Vasan RS, Pencina MJ, Wolk PA, Cobain M, Massaro JM, Kannel WB(2008), General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study, Circulation,117: 743-753.
5. Detection NCEPEPo, Adults ToHBCi (2002). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): The Program
6. Oliveira DS, Tannus LRM, Matheus ASM, Correa FH, Cobas R, Cunha EF, Gomes MB(2007),Evaluation of cardiovascular risk according to Framingham criteria in patients with tuýp 2 diabetes,Arquivos Brasileiros de Endocrinologia & Metabologia, 51(2):268-74.
7. Đỗ Thị Quỳnh, Vũ Vân Nga, Lê Thị Hòa, Lê Thị Diễm Hồng, Vũ Thị Thơm (2019), Nghiên cứu ứng dụng mô hình theo thang điểm Framingham dự đoán nguy cơ mắc bệnh tim mạch 10 năm trên nhóm nhân viên văn phòng tại Hà Nội. VNU Journal of Science: Medical and Pharmaceutical Science, 35(1):128-136
8. Nguyễn Đức Công, Nguyễn Hồng Huệ (2011), Nghiên cứu ước tính nguy cơ bệnh động mạch vành trong 10 năm tới theo thang điểm Framingham ở người thừa cân béo. Tạp chí Nghiên cứu Y học, 15(2):45-50